The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction by Paolo Verdecchia, Fabio Angeli, Giovanni Mazzotta, Giorgio Gentile, Gianpaolo Reboldi

Get full text

Aggressive blood pressure reduction in patients at high vascular risk: is it dangerous? by Fabio Angeli, Gianpaolo Reboldi, Cristina Poltronieri, Giovanni Mazzotta, Marta Garofoli, Elisa Ramundo, Alessandra Biadetti, Paolo Verdecchia

Get full text

Electrocardiography for diagnosis of left ventricular hypertrophy in hypertensive patients with atrial fibrillation by Fabio Angeli, Paolo Verdecchia, Claudio Cavallini, Adolfo Aita, Dario Turturiello, Giovanni Mazzotta, Monica Trapasso, Michelantonio De Fano, Gianpaolo Reboldi

Get full text

Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension by Paolo Verdecchia, Fabio Angeli, Giovanni Mazzotta, Claudia Bartolini, Marta Garofoli, Adolfo Aita, Cristina Poltronieri, Maria Gabriella Pinzagli, Francesca Valecchi, Stefania Martone, Elisa Ramundo, Dario Turturiello, Gianpaolo Reboldi

Get full text

Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial by Ziad Hijazi, Paolo Verdecchia, Jonas Oldgren, Ulrika Andersson, Gianpaolo Reboldi, Giuseppe Di Pasquale, Giovanni Mazzotta, Fabio Angeli, John W. Eikelboom, Michael D. Ezekowitz, Stuart J. Connolly, Salim Yusuf, Lars Wallentin

Get full text

Cardiac Contractility Modulation Therapy in Patients with Amyloid Cardiomyopathy and Heart Failure, Case Report, Review of the Biophysics of CCM Function, and AMY-CCM Registry Pres... by Procolo Marchese, Francesca Gennaro, Giovanni Mazzotta, Claudia Acciarri, Stenio Amabili, Carlo Bonanni, Antonella D’Antonio, Domenico Delfino, Luca Di Vito, Manrico Partemi, Riccardo Pascucci, Andrea Romandini, Giancarla Scalone, Simona Silenzi, Pierfrancesco Grossi

Get full text